The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Celltrion Healthcare Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
58 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STOBOCLO denosumab (rch) 60 mg/mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OSENVELT denosumab (rch) 70 mg/mL solution for injection vial.
-
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (431931)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe. -
ARTGAustralian Register of Therapeutic Goods (ARTG) information for EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle.
-
Prescription medicine registrationActive ingredients: Aflibercept.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OMLYCLO omalizumab (rch) 150 mg/ mL solution for injection in a pre-filled syringe with needle guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 20 mg/0.2 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 90mg/1 mL solution for injection pre-filled syringe with safety guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial.